Case Studies from across the Catapults
- Skills (11),
- Regional growth (18),
- Highlights (27),
- Equality, Diversity and Inclusion (12),
- International (12),
- Academic engagement (19),
- Net Zero (23),
- Health (19),
- Digital technologies (19),
- Business growth (29),
- Supply chains (6),
- Leveraging Investment (19),
Themes (Reset)
- Cross-Catapult (2),
- Cell and Gene Therapy (16),
- Compound Semiconductor Applications (13),
- Connected Places (14),
- Digital (14),
- Energy Systems (14),
- High Value Manufacturing (16),
- Medicines Discovery (15),
- Offshore Renewable Energy (15),
- Satellite Applications (14),
- Uncategorised (1),
Catapults
Medicines Discovery
Case Study
How do we supercharge and sustain skills in UK Life Sciences?
Medicines Discovery Catapult is reshaping drug discovery for patient benefit by transforming great UK science into better treatments through partnership. The life sciences industry is critical to the UK’s health, wealth, and resilience. Attracting, recruiting, training, and retaining a skilled workforce is key to ongoing success in this critical sector.
Medicines Discovery
Case Study
Bolstering the North West’s position as a life science powerhouse
Medicines Discovery Catapult is driving regional growth in the North West of England, supporting the region’s fast-growing and increasingly significant life science industry.
Medicines Discovery
Case Study
Launch of a drug discovery consortium to address the unmet therapeutic needs of people living with mental health conditions
The Psychiatry Consortium is a £4 million international collaboration between seven global pharmaceutical companies and two leading medical research charities, convened and managed by Medicines Discovery Catapult, to support high-value drug discovery projects that address the unmet therapeutic needs of people living with mental health conditions, including psychiatric symptoms associated with dementia.
Cell and Gene Therapy
Case Study
Growing new capabilities with German company Rentschler Biopharma SE
Cell and Gene Therapy Catapult partnered with German based Rentschler Biopharma to enable the establishment of new ATMP development and manufacturing capabilities in the UK, to benefit the UK and international demand and further strengthen the UK ecosystem and international supply chain.
Cell and Gene Therapy
Case Study
Advancing acute myeloid leukaemia cell therapy
A collaboration between the Cell and Gene Therapy Catapult, University College London and Imperial College London advances a novel cell therapy for the treatment of acute myeloid leukaemia.
Cell and Gene Therapy
Case Study
Developing treatments for chronic kidney disease
University spin-out Purespring Therapeutics sought expert input from the Cell and Gene Therapy Catapult to efficiently progress their pre-clinical development plans and secured one of the largest single investment to a UK biotech company from global healthcare giant Syncona.
Medicines Discovery
Case Study
Innovative treatments for a longer healthy, independent life
Figures show that we are spending more of our lives in poor health. In response, a national network is bringing together scientific expertise from across the UK to shed new light on the ageing process and help us stay healthy for longer.
Medicines Discovery
Case Study
International biobank provides database for cancer researchers worldwide
Medicines Discovery Catapult collaborated with Manchester University to create a sustainable model for a biorepository providing a critical data for researchers investigating patient side-effects from radiotherapy.
Medicines Discovery
Case Study
Developing new treatments to prevent thrombosis
LUNAC Therapeutics, a UK based drug discovery company, together with the Medicines Discovery Catapult and the University of Leeds, are working on the development of an innovative first-in-class anticoagulant treatment drug with minimal bleeding risk.
High Value Manufacturing
Case Study
Delivering vital medical equipment, saving lives
Following a call with the Prime Minister, Dick Elsy, CEO of the High Value Manufacturing Catapult convened an industrial consortium to support produce vital ventilator devices and support the NHS in its fight against Covid-19.
Cell and Gene Therapy
Case Study
Pioneering technology to increase effectiveness of gene therapeutics
A collaboration between the Cell and Gene Therapy Catapult and Synpromics set out to develop novel scalable manufacturing processes and technologies to produce viral vectors at scale.
Cell and Gene Therapy
Case Study
Enabling the development of potentially life-saving therapies
The emergence of cell therapies will potentially change the landscape of healthcare. The Cell and Gene Therapy Catapult, identified the need for a cell thawing system that would reduce barriers to the commercialisation.
Page 1 of 1